Cogstate Ltd (CGS) - Net Assets
Based on the latest financial reports, Cogstate Ltd (CGS) has net assets worth AU$47.90 Million AUD (≈ $33.89 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$64.77 Million ≈ $45.83 Million USD) and total liabilities (AU$16.88 Million ≈ $11.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Cogstate Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$47.90 Million |
| % of Total Assets | 73.95% |
| Annual Growth Rate | 40.26% |
| 5-Year Change | 65.08% |
| 10-Year Change | 247.21% |
| Growth Volatility | 4303.9 |
Cogstate Ltd - Net Assets Trend (2002–2025)
This chart illustrates how Cogstate Ltd's net assets have evolved over time, based on quarterly financial data. Also explore CGS asset base for the complete picture of this company's asset base.
Annual Net Assets for Cogstate Ltd (2002–2025)
The table below shows the annual net assets of Cogstate Ltd from 2002 to 2025. For live valuation and market cap data, see Cogstate Ltd (CGS) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$47.90 Million ≈ $33.89 Million |
+47.34% |
| 2024-06-30 | AU$32.51 Million ≈ $23.00 Million |
-42.58% |
| 2023-06-30 | AU$56.62 Million ≈ $40.06 Million |
+18.26% |
| 2022-06-30 | AU$47.88 Million ≈ $33.88 Million |
+65.00% |
| 2021-06-30 | AU$29.02 Million ≈ $20.53 Million |
+28.99% |
| 2020-06-30 | AU$22.49 Million ≈ $15.92 Million |
+56.10% |
| 2019-06-30 | AU$14.41 Million ≈ $10.20 Million |
-8.88% |
| 2018-06-30 | AU$15.81 Million ≈ $11.19 Million |
+9.46% |
| 2017-06-30 | AU$14.45 Million ≈ $10.22 Million |
+4.73% |
| 2016-06-30 | AU$13.79 Million ≈ $9.76 Million |
+77.81% |
| 2015-06-30 | AU$7.76 Million ≈ $5.49 Million |
-36.69% |
| 2014-06-30 | AU$12.25 Million ≈ $8.67 Million |
+52.42% |
| 2013-06-30 | AU$8.04 Million ≈ $5.69 Million |
-23.15% |
| 2012-06-30 | AU$10.46 Million ≈ $7.40 Million |
+55.29% |
| 2011-06-30 | AU$6.74 Million ≈ $4.77 Million |
+12.90% |
| 2010-06-30 | AU$5.97 Million ≈ $4.22 Million |
+49.78% |
| 2009-06-30 | AU$3.98 Million ≈ $2.82 Million |
+116.27% |
| 2008-06-30 | AU$1.84 Million ≈ $1.30 Million |
+37.13% |
| 2007-06-30 | AU$1.34 Million ≈ $950.44K |
-41.53% |
| 2006-06-30 | AU$2.30 Million ≈ $1.63 Million |
-21.34% |
| 2005-06-30 | AU$2.92 Million ≈ $2.07 Million |
-31.00% |
| 2004-06-30 | AU$4.23 Million ≈ $3.00 Million |
-0.27% |
| 2003-06-30 | AU$4.24 Million ≈ $3.00 Million |
+21123.06% |
| 2002-06-30 | AU$20.00K ≈ $14.15K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cogstate Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 576481300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | AU$5.76 Million | 12.04% |
| Common Stock | AU$37.76 Million | 78.83% |
| Other Comprehensive Income | AU$4.38 Million | 9.14% |
| Total Equity | AU$47.90 Million | 100.00% |
Cogstate Ltd Competitors by Market Cap
The table below lists competitors of Cogstate Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tong-Tai Machine Tool Co Ltd
TW:4526
|
$291.57 Million |
|
Global Partner Acquisition II Corp
NASDAQ:GPAC
|
$291.60 Million |
|
Orrön Energy AB (publ)
ST:ORRON
|
$291.68 Million |
|
Evolus Inc
NASDAQ:EOLS
|
$291.69 Million |
|
Eaton Vance Floating Rate Income Closed Fund
NYSE:EFT
|
$291.30 Million |
|
SPCG Public Company Limited
BK:SPCG
|
$291.24 Million |
|
Israel Land Development Urban Renewal Ltd
TA:ILDR
|
$291.04 Million |
|
Kaimei Electronic Corp
TW:2375
|
$291.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cogstate Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 40,921,806 to 47,897,815, a change of 6,976,009 (17.0%).
- Net income of 10,144,735 contributed positively to equity growth.
- Share repurchases of 4,837,068 reduced equity.
- New share issuances of 1,154,547 increased equity.
- Other comprehensive income increased equity by 2,363,833.
- Other factors decreased equity by 1,850,038.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$10.14 Million | +21.18% |
| Share Repurchases | AU$4.84 Million | -10.1% |
| Share Issuances | AU$1.15 Million | +2.41% |
| Other Comprehensive Income | AU$2.36 Million | +4.94% |
| Other Changes | AU$-1.85 Million | -3.86% |
| Total Change | AU$- | 17.05% |
Book Value vs Market Value Analysis
This analysis compares Cogstate Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.72x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 18.96x to 8.72x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-06-30 | AU$0.13 | AU$2.40 | x |
| 2004-06-30 | AU$0.12 | AU$2.40 | x |
| 2005-06-30 | AU$0.08 | AU$2.40 | x |
| 2006-06-30 | AU$0.06 | AU$2.40 | x |
| 2007-06-30 | AU$0.03 | AU$2.40 | x |
| 2008-06-30 | AU$0.04 | AU$2.40 | x |
| 2009-06-30 | AU$0.06 | AU$2.40 | x |
| 2010-06-30 | AU$0.08 | AU$2.40 | x |
| 2011-06-30 | AU$0.10 | AU$2.40 | x |
| 2012-06-30 | AU$0.14 | AU$2.40 | x |
| 2013-06-30 | AU$0.10 | AU$2.40 | x |
| 2014-06-30 | AU$0.14 | AU$2.40 | x |
| 2015-06-30 | AU$0.08 | AU$2.40 | x |
| 2016-06-30 | AU$0.12 | AU$2.40 | x |
| 2017-06-30 | AU$0.13 | AU$2.40 | x |
| 2018-06-30 | AU$0.14 | AU$2.40 | x |
| 2019-06-30 | AU$0.12 | AU$2.40 | x |
| 2020-06-30 | AU$0.14 | AU$2.40 | x |
| 2021-06-30 | AU$0.17 | AU$2.40 | x |
| 2022-06-30 | AU$0.27 | AU$2.40 | x |
| 2023-06-30 | AU$0.32 | AU$2.40 | x |
| 2024-06-30 | AU$0.24 | AU$2.40 | x |
| 2025-06-30 | AU$0.28 | AU$2.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cogstate Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.18%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.97%
- • Asset Turnover: 0.78x
- • Equity Multiplier: 1.35x
- Recent ROE (21.18%) is above the historical average (-12.84%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -20.82% | -433.83% | 0.05x | 1.05x | AU$-1.31 Million |
| 2004 | -43.32% | -1365.45% | 0.03x | 1.04x | AU$-2.26 Million |
| 2005 | -58.06% | -216.83% | 0.23x | 1.15x | AU$-1.99 Million |
| 2006 | -51.77% | -77.21% | 0.54x | 1.23x | AU$-1.42 Million |
| 2007 | -104.39% | -70.36% | 1.00x | 1.49x | AU$-1.54 Million |
| 2008 | -38.77% | -19.73% | 1.36x | 1.44x | AU$-898.41K |
| 2009 | 28.96% | 17.04% | 1.30x | 1.31x | AU$755.41K |
| 2010 | 23.32% | 17.27% | 1.10x | 1.23x | AU$795.07K |
| 2011 | -13.43% | -10.40% | 1.04x | 1.25x | AU$-1.58 Million |
| 2012 | 23.99% | 20.41% | 1.01x | 1.16x | AU$1.46 Million |
| 2013 | -22.22% | -15.70% | 1.13x | 1.25x | AU$-2.59 Million |
| 2014 | -29.88% | -31.70% | 0.81x | 1.16x | AU$-4.89 Million |
| 2015 | -50.05% | -31.49% | 1.12x | 1.41x | AU$-4.66 Million |
| 2016 | 19.15% | 9.69% | 1.39x | 1.42x | AU$1.26 Million |
| 2017 | -5.90% | -2.44% | 1.60x | 1.51x | AU$-2.30 Million |
| 2018 | -4.62% | -1.95% | 1.47x | 1.61x | AU$-2.31 Million |
| 2019 | -24.22% | -11.43% | 1.11x | 1.90x | AU$-4.93 Million |
| 2020 | -12.97% | -8.59% | 0.73x | 2.06x | AU$-5.17 Million |
| 2021 | 24.18% | 16.01% | 0.64x | 2.36x | AU$4.11 Million |
| 2022 | 21.66% | 16.72% | 0.73x | 1.78x | AU$5.58 Million |
| 2023 | 9.37% | 8.82% | 0.74x | 1.43x | AU$-357.91K |
| 2024 | 13.32% | 8.22% | 1.15x | 1.41x | AU$1.36 Million |
| 2025 | 21.18% | 19.97% | 0.78x | 1.35x | AU$5.35 Million |
Industry Comparison
This section compares Cogstate Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $4,333,919
- Average return on equity (ROE) among peers: -705.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cogstate Ltd (CGS) | AU$47.90 Million | -20.82% | 0.35x | $291.33 Million |
| Adheris Health Limited (AHE) | $1.05 Million | -5741.10% | 36.99x | $137.04 |
| Alcidion Group Ltd (ALC) | $13.24 Million | -0.64% | 0.88x | $95.02 Million |
| ARTRYA Ltd (AYA) | $16.80 Million | -83.31% | 0.13x | $455.29 Million |
| Beamtree Holdings Ltd (BMT) | $29.22 Million | 1.31% | 0.10x | $24.68 Million |
| Careteq Ltd (CTQ) | $9.61 Million | -54.39% | 0.27x | $2.06 Million |
| Doctor Care Anywhere Group Plc (DOC) | $-5.53 Million | 0.00% | 0.00x | $41.51 Million |
| Echoiq Ltd (EIQ) | $-147.39K | 0.00% | 0.00x | $468.78 Million |
| Emyria Ltd (EMD) | $2.43 Million | -472.33% | 1.24x | $28.53 Million |
| Enlitic Inc (ENL) | $-27.66 Million | 0.00% | 0.00x | $5.90 Million |
About Cogstate Ltd
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, includ… Read more